This kid has no idea what he's talking about. The above paragraph is largely speculative and non-sensical, not to mention not helpful in any way to the OP's question.
AFAIK, the cross-tolerance of BZP/MDMA is not thoroughly studied (beyond anecdotal evidence -> though if I'm wrong, someone please correct me) and such non-scientific reports are hard to judge, since BZP and MDMA each build tolerances quickly in users, in addition to the subjective nature of drug experiences. If I had to hazard an educated guess, I would expect them to show some degree of cross-tolerance.
Interestingly, BZP has been shown to cause cross-sensitization with methamphetamine (Brennan K, Johnstone A, Fitzmaurice P, Lea R, Schenk S (2007). "Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA)". Drug Alcohol Depend 88 (2-3): 204–13. doi:10.1016/j.drugalcdep.2006.10.016. PMID 17125936.) The paper referenced suggests BZP induces sensitization to strongly dompaminergic amphetamines. One could go as far as to speculate it could simultaneously build a tolerance for MDMA's SERT effects and simultaneously sensitize the DA system: like I said above - I don't think this is well-studied.